MGMT (O6-methylguanine-DNA methyltransferase) is involved in DNA repair mechanisms and is a known determinant of resistance to alkylating agents such as TMZ, the standard chemotherapeutic drug for GBM. The gene discussed is MGMT; the disease is glioblastoma.